Serrated Blade Applicator Kit (12 Sample), REF: 552687, For use with the Spife Nexus system, Cont...

FDA Device Recall #Z-1975-2023 — Class II — May 2, 2023

Recall Summary

Recall Number Z-1975-2023
Classification Class II — Moderate risk
Date Initiated May 2, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Helena Laboratories, Corp.
Location Beaumont, TX
Product Type Devices
Quantity 32 units

Product Description

Serrated Blade Applicator Kit (12 Sample), REF: 552687, For use with the Spife Nexus system, Contents: 30 Blade Applicators. used in invitro diagnostics

Reason for Recall

Packaging for a serrated blade applicator kit (12 Sample) may contain a serrated blade applicator (18 sample). This results in a characteristic pattern of missed or light samples on the gel, leading to incorrect or no result, or delay in result.

Distribution Pattern

Distribution to US states of PA, NE, MI, FL, AR, NY, TX, and CA, and to Thailand.

Lot / Code Information

Lot # 3-22, UDI-DI: M5255526870

Other Recalls from Helena Laboratories, Corp.

Recall # Classification Product Date
Z-1244-2022 Class II V8 Immunodisplacement Kit REF 1803 Apr 6, 2022
Z-1108-2021 Class II Cascade Abrazo aPTT Test Card - Product Usage: ... Jan 5, 2021
Z-0635-2021 Class II K-ACT Actalyke Clotting Test Tubes that are use... Nov 9, 2020
Z-1950-2019 Class II ColoCARE, Cat. No. 5651, packaged 50 envelopes/... Aug 8, 2018
Z-1949-2019 Class II ColoCARE, Cat. No. 5650, packaged 250 envelopes... Aug 8, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.